Citations 1
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
Shen, Weiwei , Patnaik, Mrinal M. , Ruiz, Autumn, Russell, Stephen J. , Peng, Kah-Whye , Schulze, Autumn J. , Russell, Stephen J
Blood | December 28, 2015 | Volume: 127 | Issue: 11 | Pages: 1449-1458
Key Points IV therapy with oncolytic VSV-IFNβ-NIS virus extends survival of immunocompetent mice with AML. The therapeutic outcome of VSV-IFNβ-NIS–treated mice with AML is augmented by anti-PD-L1 immunotherapy.